The Tough Tech problem we are solving
Nervoid is addressing a foundational challenge in biology and drug discovery: the inability to extract mechanistic, actionable insights directly from cellular imaging. Cellular phneotyping is a major bottleneck in current pipelines and is a source of costly failures. Traditional approaches rely on manual analysis or simple metrics, intensity, morphology, or ROI statistics, leaving the vast information in complex microscopy datasets untapped. Nervoid’s platform combines AI and advanced imaging analysis to decode cellular signaling, predict gene expression, and detect subtle phenotypic changes, turning raw biological images into interpretable, predictive date that can accelerate research, drug discovery, and precision medicine.
About our solution
Nervoid uses AI-vision to turn high-dimensional cellular images into actionable biological insights. By analyzing multi-channel, time-lapse, and 3D data from iPSC-derived models, organoids, and primary cells, Nervoid can infer signaling pathway activity, predict gene expression, and detect early cellular responses, enabling automated target discovery, mechanism-of-action and toxicity profiling. This allows preclinical teams to move from raw images to data-driven decisions, accelerating compound screening, safety assessment, and therapeutic development.